

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 9.30749665 |
| 2 | porphyrin-containing compound biosynthetic process (GO:0006779) | 7.84062993 |
| 3 | heme biosynthetic process (GO:0006783) | 7.75118679 |
| 4 | tetrapyrrole biosynthetic process (GO:0033014) | 6.92611512 |
| 5 | porphyrin-containing compound metabolic process (GO:0006778) | 6.33256484 |
| 6 | heme metabolic process (GO:0042168) | 6.29404118 |
| 7 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.97117874 |
| 8 | skeletal muscle contraction (GO:0003009) | 5.73975898 |
| 9 | actin-mediated cell contraction (GO:0070252) | 5.57678075 |
| 10 | regulation of skeletal muscle contraction (GO:0014819) | 5.31872333 |
| 11 | creatine metabolic process (GO:0006600) | 5.19966041 |
| 12 | erythrocyte maturation (GO:0043249) | 4.96295261 |
| 13 | erythrocyte development (GO:0048821) | 4.86647278 |
| 14 | striated muscle contraction (GO:0006941) | 4.38498143 |
| 15 | tetrapyrrole metabolic process (GO:0033013) | 4.16811597 |
| 16 | gluconeogenesis (GO:0006094) | 4.15776878 |
| 17 | negative regulation of cell size (GO:0045792) | 4.07036133 |
| 18 | actin filament-based movement (GO:0030048) | 3.94572717 |
| 19 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.90052949 |
| 20 | hemoglobin metabolic process (GO:0020027) | 3.89106143 |
| 21 | hexose biosynthetic process (GO:0019319) | 3.80230403 |
| 22 | pigment biosynthetic process (GO:0046148) | 3.79232293 |
| 23 | IMP biosynthetic process (GO:0006188) | 3.79053213 |
| 24 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.71110390 |
| 25 | monosaccharide biosynthetic process (GO:0046364) | 3.69130836 |
| 26 | myofibril assembly (GO:0030239) | 3.60577135 |
| 27 | glycogen catabolic process (GO:0005980) | 3.54231000 |
| 28 | negative regulation of necroptotic process (GO:0060546) | 3.52481385 |
| 29 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.51626731 |
| 30 | glycolytic process (GO:0006096) | 3.51032232 |
| 31 | oxygen transport (GO:0015671) | 3.50391780 |
| 32 | response to lead ion (GO:0010288) | 3.50385514 |
| 33 | skeletal muscle fiber development (GO:0048741) | 3.49971625 |
| 34 | positive regulation of myotube differentiation (GO:0010831) | 3.49074246 |
| 35 | glucan biosynthetic process (GO:0009250) | 3.48538871 |
| 36 | glycogen biosynthetic process (GO:0005978) | 3.48538871 |
| 37 | regulation of relaxation of muscle (GO:1901077) | 3.48354927 |
| 38 | response to methylmercury (GO:0051597) | 3.47549959 |
| 39 | response to muscle activity (GO:0014850) | 3.44906470 |
| 40 | IMP metabolic process (GO:0046040) | 3.42577506 |
| 41 | cardiac muscle contraction (GO:0060048) | 3.41585761 |
| 42 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.41218423 |
| 43 | response to insecticide (GO:0017085) | 3.39100065 |
| 44 | skeletal muscle adaptation (GO:0043501) | 3.36678690 |
| 45 | purine nucleotide salvage (GO:0032261) | 3.34048212 |
| 46 | fructose metabolic process (GO:0006000) | 3.32049716 |
| 47 | DNA deamination (GO:0045006) | 3.30928595 |
| 48 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.30871087 |
| 49 | tricarboxylic acid cycle (GO:0006099) | 3.25623893 |
| 50 | oxaloacetate metabolic process (GO:0006107) | 3.23115043 |
| 51 | myeloid cell development (GO:0061515) | 3.22243678 |
| 52 | glucan catabolic process (GO:0009251) | 3.21675651 |
| 53 | pigment metabolic process (GO:0042440) | 3.20308314 |
| 54 | oxidative phosphorylation (GO:0006119) | 3.13711161 |
| 55 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.11316170 |
| 56 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.10273376 |
| 57 | gas transport (GO:0015669) | 3.10108009 |
| 58 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.09517533 |
| 59 | lysine metabolic process (GO:0006553) | 3.04320294 |
| 60 | lysine catabolic process (GO:0006554) | 3.04320294 |
| 61 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.02787919 |
| 62 | 2-oxoglutarate metabolic process (GO:0006103) | 3.02448021 |
| 63 | purine-containing compound salvage (GO:0043101) | 3.01610552 |
| 64 | muscle contraction (GO:0006936) | 2.99911029 |
| 65 | proline biosynthetic process (GO:0006561) | 2.99310998 |
| 66 | negative regulation of necrotic cell death (GO:0060547) | 2.99040915 |
| 67 | regulation of response to osmotic stress (GO:0047484) | 2.96305346 |
| 68 | GDP-mannose metabolic process (GO:0019673) | 2.96118476 |
| 69 | NADH metabolic process (GO:0006734) | 2.95708034 |
| 70 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.94529089 |
| 71 | DNA replication initiation (GO:0006270) | 2.93938068 |
| 72 | erythrocyte differentiation (GO:0030218) | 2.93663488 |
| 73 | DNA strand elongation (GO:0022616) | 2.93024352 |
| 74 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.91854674 |
| 75 | cellular polysaccharide catabolic process (GO:0044247) | 2.90088207 |
| 76 | modulation by virus of host process (GO:0019054) | 2.87635262 |
| 77 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.85741889 |
| 78 | regulation of translational termination (GO:0006449) | 2.85600789 |
| 79 | mitotic chromosome condensation (GO:0007076) | 2.84844903 |
| 80 | COPI coating of Golgi vesicle (GO:0048205) | 2.83410209 |
| 81 | Golgi transport vesicle coating (GO:0048200) | 2.83410209 |
| 82 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.83409919 |
| 83 | DNA unwinding involved in DNA replication (GO:0006268) | 2.83238561 |
| 84 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.79451399 |
| 85 | ribosomal small subunit assembly (GO:0000028) | 2.79103165 |
| 86 | nuclear envelope reassembly (GO:0031468) | 2.78920232 |
| 87 | mitotic nuclear envelope reassembly (GO:0007084) | 2.78920232 |
| 88 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.78899816 |
| 89 | muscle cell cellular homeostasis (GO:0046716) | 2.78799522 |
| 90 | myotube cell development (GO:0014904) | 2.78424486 |
| 91 | protein maturation by protein folding (GO:0022417) | 2.78258935 |
| 92 | cardiac myofibril assembly (GO:0055003) | 2.77930788 |
| 93 | ribosomal small subunit biogenesis (GO:0042274) | 2.77097203 |
| 94 | pyrimidine nucleoside salvage (GO:0043097) | 2.76240959 |
| 95 | pyrimidine-containing compound salvage (GO:0008655) | 2.76240959 |
| 96 | cellular hyperosmotic response (GO:0071474) | 2.76085240 |
| 97 | sequestering of actin monomers (GO:0042989) | 2.75160299 |
| 98 | glucose metabolic process (GO:0006006) | 2.74235300 |
| 99 | muscle filament sliding (GO:0030049) | 2.72925139 |
| 100 | actin-myosin filament sliding (GO:0033275) | 2.72925139 |
| 101 | maternal placenta development (GO:0001893) | 2.72242691 |
| 102 | iron-sulfur cluster assembly (GO:0016226) | 2.71771684 |
| 103 | metallo-sulfur cluster assembly (GO:0031163) | 2.71771684 |
| 104 | glycogen metabolic process (GO:0005977) | 2.70616485 |
| 105 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.68132279 |
| 106 | modulation by symbiont of host cellular process (GO:0044068) | 2.67942741 |
| 107 | cofactor biosynthetic process (GO:0051188) | 2.67339382 |
| 108 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.67111605 |
| 109 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.66973471 |
| 110 | protein autoprocessing (GO:0016540) | 2.64870629 |
| 111 | formation of translation preinitiation complex (GO:0001731) | 2.64463532 |
| 112 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.62012793 |
| 113 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.62012793 |
| 114 | glucan metabolic process (GO:0044042) | 2.61700866 |
| 115 | cellular glucan metabolic process (GO:0006073) | 2.61700866 |
| 116 | nucleotide salvage (GO:0043173) | 2.61646236 |
| 117 | muscle system process (GO:0003012) | 2.61242737 |
| 118 | response to inactivity (GO:0014854) | 2.60884238 |
| 119 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.58885053 |
| 120 | polysaccharide catabolic process (GO:0000272) | 2.58224383 |
| 121 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.57188076 |
| 122 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.55670640 |
| 123 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.55178947 |
| 124 | valine metabolic process (GO:0006573) | 2.54260229 |
| 125 | actomyosin structure organization (GO:0031032) | 2.53748136 |
| 126 | DNA replication checkpoint (GO:0000076) | 2.53100015 |
| 127 | tricarboxylic acid metabolic process (GO:0072350) | 2.52367281 |
| 128 | aspartate family amino acid catabolic process (GO:0009068) | 2.52300240 |
| 129 | activation of MAPKKK activity (GO:0000185) | 2.50602698 |
| 130 | regulation of necroptotic process (GO:0060544) | 2.49010346 |
| 131 | embryonic hemopoiesis (GO:0035162) | 2.46706250 |
| 132 | negative regulation of B cell apoptotic process (GO:0002903) | 2.46551822 |
| 133 | sarcomere organization (GO:0045214) | 2.46320686 |
| 134 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.44813799 |
| 135 | translational elongation (GO:0006414) | 2.43186076 |
| 136 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.43066409 |
| 137 | response to arsenic-containing substance (GO:0046685) | 2.42284445 |
| 138 | platelet formation (GO:0030220) | 2.40943317 |
| 139 | galactose catabolic process (GO:0019388) | 2.40850817 |
| 140 | protein retention in ER lumen (GO:0006621) | 2.39658211 |
| 141 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.38633708 |
| 142 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.38633708 |
| 143 | pentose-phosphate shunt (GO:0006098) | 2.38154192 |
| 144 | AMP metabolic process (GO:0046033) | 2.36977337 |
| 145 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.36120980 |
| 146 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.36120980 |
| 147 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.34392197 |
| 148 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.34392197 |
| 149 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.34392197 |
| 150 | viral transcription (GO:0019083) | 2.34208848 |
| 151 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.32960351 |
| 152 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.32960351 |
| 153 | tetrahydrofolate metabolic process (GO:0046653) | 2.32078038 |
| 154 | megakaryocyte development (GO:0035855) | 2.31070684 |
| 155 | proteasome assembly (GO:0043248) | 2.30454353 |
| 156 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.30044883 |
| 157 | mitotic sister chromatid segregation (GO:0000070) | 2.29771363 |
| 158 | cellular response to dexamethasone stimulus (GO:0071549) | 2.28674164 |
| 159 | regulation of translational fidelity (GO:0006450) | 2.28660818 |
| 160 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.28342721 |
| 161 | mitochondrial fusion (GO:0008053) | 2.27944969 |
| 162 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.26561306 |
| 163 | barbed-end actin filament capping (GO:0051016) | 2.26520646 |
| 164 | translational termination (GO:0006415) | 2.25090539 |
| 165 | telomere maintenance via recombination (GO:0000722) | 2.24443556 |
| 166 | T cell apoptotic process (GO:0070231) | 2.23696661 |
| 167 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 2.23307736 |
| 168 | protoporphyrinogen IX metabolic process (GO:0046501) | 10.1614982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.89312558 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.89120361 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.54972831 |
| 4 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.42122737 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.37926715 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.31321334 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16271083 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.10077243 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06383900 |
| 10 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05556947 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.05181461 |
| 12 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.02612103 |
| 13 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.94132436 |
| 14 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.89429930 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.87676732 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.86367379 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.84236223 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.84183404 |
| 19 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81528336 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.79142907 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.78212103 |
| 22 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.76084728 |
| 23 | GATA1_19941826_ChIP-Seq_K562_Human | 1.75952183 |
| 24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.75220681 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.73304979 |
| 26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72865443 |
| 27 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.71666011 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71662337 |
| 29 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.66973092 |
| 30 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.66688213 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.65736786 |
| 32 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.63748265 |
| 33 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60854999 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.59485208 |
| 35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.58975353 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58683921 |
| 37 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.58602452 |
| 38 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.58103242 |
| 39 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.56936905 |
| 40 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.55056896 |
| 41 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.54725166 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51871051 |
| 43 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.51574186 |
| 44 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.49799178 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49563529 |
| 46 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.48765503 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.47276056 |
| 48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.46196126 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46000969 |
| 50 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44528560 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44514976 |
| 52 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.43960257 |
| 53 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.43932060 |
| 54 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.38539570 |
| 55 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.37867194 |
| 56 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.37400645 |
| 57 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.35942980 |
| 58 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.35132613 |
| 59 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.35086439 |
| 60 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.34872831 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34619466 |
| 62 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.33768079 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.33295028 |
| 64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33227582 |
| 65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32477283 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.31641327 |
| 67 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29732897 |
| 68 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.29130216 |
| 69 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.28338964 |
| 70 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.27473103 |
| 71 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.27182683 |
| 72 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.25683915 |
| 73 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.25492248 |
| 74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23099793 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.20783337 |
| 76 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.20475455 |
| 77 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.20216764 |
| 78 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.19265362 |
| 79 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18836491 |
| 80 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.18200583 |
| 81 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.16923454 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16887371 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16577276 |
| 84 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.15938137 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15817824 |
| 86 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15591967 |
| 87 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.15574709 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14746011 |
| 89 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14200952 |
| 90 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14112228 |
| 91 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.14061239 |
| 92 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.14022949 |
| 93 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13771969 |
| 94 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.13604663 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13282969 |
| 96 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.13280098 |
| 97 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12724140 |
| 98 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12371090 |
| 99 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.12237383 |
| 100 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11904128 |
| 101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.11876600 |
| 102 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11504376 |
| 103 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10191624 |
| 104 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10168040 |
| 105 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10084708 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09837627 |
| 107 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09726009 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08518917 |
| 109 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.08494172 |
| 110 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08192083 |
| 111 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08089790 |
| 112 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.07863090 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07748957 |
| 114 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.07555418 |
| 115 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07270492 |
| 116 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05657828 |
| 117 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.05280242 |
| 118 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04747442 |
| 119 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04237096 |
| 120 | P68_20966046_ChIP-Seq_HELA_Human | 1.04042991 |
| 121 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03341790 |
| 122 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02959965 |
| 123 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02494729 |
| 124 | MAF_26560356_Chip-Seq_TH2_Human | 1.02085453 |
| 125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01914194 |
| 126 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01896136 |
| 127 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01837335 |
| 128 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.01674289 |
| 129 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.01592255 |
| 130 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01061924 |
| 131 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00731196 |
| 132 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00013986 |
| 133 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.99813217 |
| 134 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.99639798 |
| 135 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.99118013 |
| 136 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97962612 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97774471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 6.86014140 |
| 2 | MP0004147_increased_porphyrin_level | 5.16422953 |
| 3 | MP0005451_abnormal_body_composition | 4.65404524 |
| 4 | MP0005083_abnormal_biliary_tract | 3.18979083 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.15982220 |
| 6 | MP0000749_muscle_degeneration | 2.50710497 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.30441195 |
| 8 | MP0003646_muscle_fatigue | 2.28594610 |
| 9 | MP0003111_abnormal_nucleus_morphology | 2.18672296 |
| 10 | MP0004185_abnormal_adipocyte_glucose | 2.17785344 |
| 11 | MP0006036_abnormal_mitochondrial_physio | 2.15721293 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.14940729 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.12200657 |
| 14 | MP0000733_abnormal_muscle_development | 2.03019245 |
| 15 | MP0003186_abnormal_redox_activity | 1.95510332 |
| 16 | MP0005058_abnormal_lysosome_morphology | 1.88843224 |
| 17 | MP0005397_hematopoietic_system_phenotyp | 1.88811069 |
| 18 | MP0001545_abnormal_hematopoietic_system | 1.88811069 |
| 19 | MP0004510_myositis | 1.88086801 |
| 20 | MP0010094_abnormal_chromosome_stability | 1.81422070 |
| 21 | MP0003077_abnormal_cell_cycle | 1.78757815 |
| 22 | MP0004957_abnormal_blastocyst_morpholog | 1.76211417 |
| 23 | MP0000685_abnormal_immune_system | 1.74415674 |
| 24 | MP0003693_abnormal_embryo_hatching | 1.74164862 |
| 25 | MP0009840_abnormal_foam_cell | 1.68174315 |
| 26 | MP0000003_abnormal_adipose_tissue | 1.67676726 |
| 27 | MP0002269_muscular_atrophy | 1.58786021 |
| 28 | MP0005375_adipose_tissue_phenotype | 1.55159511 |
| 29 | MP0005620_abnormal_muscle_contractility | 1.52153667 |
| 30 | MP0000747_muscle_weakness | 1.52035787 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.42903896 |
| 32 | MP0008775_abnormal_heart_ventricle | 1.42550493 |
| 33 | MP0003283_abnormal_digestive_organ | 1.42523972 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.39187699 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.38623069 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 1.36110172 |
| 37 | MP0000751_myopathy | 1.34213007 |
| 38 | MP0009278_abnormal_bone_marrow | 1.33755783 |
| 39 | MP0002822_catalepsy | 1.33643819 |
| 40 | MP0005330_cardiomyopathy | 1.33163517 |
| 41 | MP0004087_abnormal_muscle_fiber | 1.32875837 |
| 42 | MP0000750_abnormal_muscle_regeneration | 1.31629355 |
| 43 | MP0006138_congestive_heart_failure | 1.31304687 |
| 44 | MP0008260_abnormal_autophagy | 1.30661083 |
| 45 | MP0002398_abnormal_bone_marrow | 1.30236265 |
| 46 | MP0010307_abnormal_tumor_latency | 1.30157930 |
| 47 | MP0004084_abnormal_cardiac_muscle | 1.28843525 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.23689958 |
| 49 | MP0004858_abnormal_nervous_system | 1.22729226 |
| 50 | MP0000759_abnormal_skeletal_muscle | 1.21578033 |
| 51 | MP0002722_abnormal_immune_system | 1.20118283 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.19655358 |
| 53 | MP0001661_extended_life_span | 1.18215791 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.17514139 |
| 55 | MP0005670_abnormal_white_adipose | 1.16523900 |
| 56 | MP0000609_abnormal_liver_physiology | 1.14845775 |
| 57 | MP0005076_abnormal_cell_differentiation | 1.14685721 |
| 58 | MP0004145_abnormal_muscle_electrophysio | 1.14280074 |
| 59 | MP0001730_embryonic_growth_arrest | 1.13412120 |
| 60 | MP0002106_abnormal_muscle_physiology | 1.10689632 |
| 61 | MP0008007_abnormal_cellular_replicative | 1.08787425 |
| 62 | MP0003763_abnormal_thymus_physiology | 1.08167458 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.08091678 |
| 64 | MP0005671_abnormal_response_to | 1.07802848 |
| 65 | MP0002132_abnormal_respiratory_system | 1.06409875 |
| 66 | MP0002429_abnormal_blood_cell | 1.06221760 |
| 67 | MP0003045_fibrosis | 1.05531432 |
| 68 | MP0004036_abnormal_muscle_relaxation | 1.04772163 |
| 69 | MP0004233_abnormal_muscle_weight | 1.02431435 |
| 70 | MP0009643_abnormal_urine_homeostasis | 1.02311426 |
| 71 | MP0005387_immune_system_phenotype | 1.01966919 |
| 72 | MP0001790_abnormal_immune_system | 1.01966919 |
| 73 | MP0000490_abnormal_crypts_of | 1.01748372 |
| 74 | MP0000358_abnormal_cell_content/ | 1.01339185 |
| 75 | MP0002019_abnormal_tumor_incidence | 1.01330442 |
| 76 | MP0005501_abnormal_skin_physiology | 1.00952072 |
| 77 | MP0000350_abnormal_cell_proliferation | 1.00438882 |
| 78 | MP0000313_abnormal_cell_death | 0.98064819 |
| 79 | MP0002108_abnormal_muscle_morphology | 0.97197329 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 0.96855740 |
| 81 | MP0000598_abnormal_liver_morphology | 0.96071632 |
| 82 | MP0003566_abnormal_cell_adhesion | 0.95508304 |
| 83 | MP0002971_abnormal_brown_adipose | 0.94937719 |
| 84 | MP0003300_gastrointestinal_ulcer | 0.93453163 |
| 85 | MP0001835_abnormal_antigen_presentation | 0.90831455 |
| 86 | MP0001853_heart_inflammation | 0.90458145 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.90039085 |
| 88 | MP0000343_altered_response_to | 0.89818484 |
| 89 | MP0005266_abnormal_metabolism | 0.89799422 |
| 90 | MP0006035_abnormal_mitochondrial_morpho | 0.88835327 |
| 91 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88535534 |
| 92 | MP0010630_abnormal_cardiac_muscle | 0.88474552 |
| 93 | MP0004808_abnormal_hematopoietic_stem | 0.86588932 |
| 94 | MP0002138_abnormal_hepatobiliary_system | 0.85211979 |
| 95 | MP0002405_respiratory_system_inflammati | 0.84029482 |
| 96 | MP0005464_abnormal_platelet_physiology | 0.83786487 |
| 97 | MP0004130_abnormal_muscle_cell | 0.83657217 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.82559735 |
| 99 | MP0004043_abnormal_pH_regulation | 0.81145403 |
| 100 | MP0006054_spinal_hemorrhage | 0.81056112 |
| 101 | MP0001873_stomach_inflammation | 0.81006636 |
| 102 | MP0004215_abnormal_myocardial_fiber | 0.80492973 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.80324095 |
| 104 | * MP0002080_prenatal_lethality | 0.79837565 |
| 105 | MP0005365_abnormal_bile_salt | 0.79760834 |
| 106 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79698318 |
| 107 | MP0000858_altered_metastatic_potential | 0.79613815 |
| 108 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79576625 |
| 109 | MP0000678_abnormal_parathyroid_gland | 0.79188426 |
| 110 | MP0008058_abnormal_DNA_repair | 0.78290467 |
| 111 | MP0009931_abnormal_skin_appearance | 0.77969084 |
| 112 | MP0005369_muscle_phenotype | 0.77951019 |
| 113 | MP0000716_abnormal_immune_system | 0.76568302 |
| 114 | MP0001544_abnormal_cardiovascular_syste | 0.76013448 |
| 115 | MP0005385_cardiovascular_system_phenoty | 0.76013448 |
| 116 | MP0003436_decreased_susceptibility_to | 0.75911254 |
| 117 | MP0002972_abnormal_cardiac_muscle | 0.75703669 |
| 118 | MP0005085_abnormal_gallbladder_physiolo | 0.75569343 |
| 119 | MP0008872_abnormal_physiological_respon | 0.75206475 |
| 120 | MP0005025_abnormal_response_to | 0.74266683 |
| 121 | MP0003453_abnormal_keratinocyte_physiol | 0.72663496 |
| 122 | MP0003075_altered_response_to | 0.72070092 |
| 123 | MP0003303_peritoneal_inflammation | 0.69027167 |
| 124 | MP0002127_abnormal_cardiovascular_syste | 0.67026159 |
| 125 | MP0005165_increased_susceptibility_to | 0.66763387 |
| 126 | MP0002970_abnormal_white_adipose | 0.66392173 |
| 127 | MP0003828_pulmonary_edema | 0.63512368 |
| 128 | MP0003950_abnormal_plasma_membrane | 0.56175616 |
| 129 | MP0001727_abnormal_embryo_implantation | 0.55631296 |
| 130 | MP0008874_decreased_physiological_sensi | 0.53998607 |
| 131 | MP0003786_premature_aging | 0.53968973 |
| 132 | MP0005166_decreased_susceptibility_to | 0.53064009 |
| 133 | MP0009672_abnormal_birth_weight | 0.52223324 |
| 134 | MP0002060_abnormal_skin_morphology | 0.49401626 |
| 135 | MP0001849_ear_inflammation | 0.49191426 |
| 136 | MP0001348_abnormal_lacrimal_gland | 0.49061899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 8.25456201 |
| 2 | Poikilocytosis (HP:0004447) | 7.01385093 |
| 3 | Reticulocytosis (HP:0001923) | 6.16731932 |
| 4 | Cholelithiasis (HP:0001081) | 5.16508566 |
| 5 | Abnormal gallbladder morphology (HP:0012437) | 4.77008977 |
| 6 | Acanthocytosis (HP:0001927) | 4.76631886 |
| 7 | Hyperbilirubinemia (HP:0002904) | 4.27856401 |
| 8 | Paralysis (HP:0003470) | 4.27575773 |
| 9 | Abnormality of reticulocytes (HP:0004312) | 4.23982026 |
| 10 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.11155292 |
| 11 | Diaphragmatic weakness (HP:0009113) | 4.04666339 |
| 12 | Neck muscle weakness (HP:0000467) | 3.88705451 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 3.61514301 |
| 14 | Increased variability in muscle fiber diameter (HP:0003557) | 3.50326932 |
| 15 | Abnormal number of erythroid precursors (HP:0012131) | 3.48444476 |
| 16 | Myoglobinuria (HP:0002913) | 3.44994432 |
| 17 | Rhabdomyolysis (HP:0003201) | 3.39612865 |
| 18 | Distal lower limb amyotrophy (HP:0008944) | 3.35526344 |
| 19 | Abnormality of the gallbladder (HP:0005264) | 3.32346710 |
| 20 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.13175302 |
| 21 | Increased serum ferritin (HP:0003281) | 3.11782532 |
| 22 | Abnormal gallbladder physiology (HP:0012438) | 3.11265061 |
| 23 | Cholecystitis (HP:0001082) | 3.11265061 |
| 24 | Hypochromic microcytic anemia (HP:0004840) | 3.02630324 |
| 25 | Abnormality of the calf musculature (HP:0001430) | 2.97033370 |
| 26 | Calcaneovalgus deformity (HP:0001848) | 2.93485324 |
| 27 | Abnormality of iron homeostasis (HP:0011031) | 2.90036275 |
| 28 | Exercise-induced myalgia (HP:0003738) | 2.88373711 |
| 29 | Muscle fiber inclusion bodies (HP:0100299) | 2.82106088 |
| 30 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.75816853 |
| 31 | Rimmed vacuoles (HP:0003805) | 2.69650604 |
| 32 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.66980825 |
| 33 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.66980825 |
| 34 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.66053115 |
| 35 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.59872332 |
| 36 | Hepatic necrosis (HP:0002605) | 2.56626990 |
| 37 | Deformed tarsal bones (HP:0008119) | 2.55261818 |
| 38 | Bulbar palsy (HP:0001283) | 2.52380881 |
| 39 | Cutaneous photosensitivity (HP:0000992) | 2.48798266 |
| 40 | Nemaline bodies (HP:0003798) | 2.47530372 |
| 41 | Spinal rigidity (HP:0003306) | 2.46580009 |
| 42 | Osteomalacia (HP:0002749) | 2.46452389 |
| 43 | Frequent falls (HP:0002359) | 2.46417517 |
| 44 | Polycythemia (HP:0001901) | 2.42969029 |
| 45 | Achilles tendon contracture (HP:0001771) | 2.40971941 |
| 46 | Microcytic anemia (HP:0001935) | 2.39215252 |
| 47 | Increased connective tissue (HP:0009025) | 2.37263282 |
| 48 | Multiple enchondromatosis (HP:0005701) | 2.36371186 |
| 49 | Ileus (HP:0002595) | 2.33952864 |
| 50 | Petechiae (HP:0000967) | 2.32436462 |
| 51 | Fatigue (HP:0012378) | 2.30925768 |
| 52 | Hypoglycemic coma (HP:0001325) | 2.30843669 |
| 53 | Hepatocellular necrosis (HP:0001404) | 2.30170636 |
| 54 | Ventricular tachycardia (HP:0004756) | 2.29331365 |
| 55 | Generalized muscle weakness (HP:0003324) | 2.26206640 |
| 56 | Malignant hyperthermia (HP:0002047) | 2.25908402 |
| 57 | Foot dorsiflexor weakness (HP:0009027) | 2.24293184 |
| 58 | Birth length less than 3rd percentile (HP:0003561) | 2.24140934 |
| 59 | Progressive muscle weakness (HP:0003323) | 2.23769106 |
| 60 | Lower limb amyotrophy (HP:0007210) | 2.23577798 |
| 61 | Cerebral palsy (HP:0100021) | 2.20957121 |
| 62 | Muscle fiber splitting (HP:0003555) | 2.19393815 |
| 63 | Slender build (HP:0001533) | 2.19339161 |
| 64 | Type 1 muscle fiber predominance (HP:0003803) | 2.18985279 |
| 65 | EMG: neuropathic changes (HP:0003445) | 2.18936952 |
| 66 | Exercise intolerance (HP:0003546) | 2.18872715 |
| 67 | Abnormality of the foot musculature (HP:0001436) | 2.17254568 |
| 68 | Ulnar deviation of the wrist (HP:0003049) | 2.14188604 |
| 69 | Hypochromic anemia (HP:0001931) | 2.13207024 |
| 70 | Abnormality of the Achilles tendon (HP:0005109) | 2.12067699 |
| 71 | Trismus (HP:0000211) | 2.11985796 |
| 72 | Increased muscle lipid content (HP:0009058) | 2.11797141 |
| 73 | Limb-girdle muscle atrophy (HP:0003797) | 2.08500082 |
| 74 | Muscle stiffness (HP:0003552) | 2.08062867 |
| 75 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.07781137 |
| 76 | Distal arthrogryposis (HP:0005684) | 2.06934092 |
| 77 | Pustule (HP:0200039) | 2.06834911 |
| 78 | Myopathic facies (HP:0002058) | 2.05867922 |
| 79 | Myotonia (HP:0002486) | 2.05253539 |
| 80 | Urticaria (HP:0001025) | 2.04903282 |
| 81 | Hyporeflexia of lower limbs (HP:0002600) | 2.03986376 |
| 82 | Nausea (HP:0002018) | 2.03965762 |
| 83 | EMG: myopathic abnormalities (HP:0003458) | 2.03057808 |
| 84 | Difficulty climbing stairs (HP:0003551) | 2.00880488 |
| 85 | Palpitations (HP:0001962) | 2.00627184 |
| 86 | Bundle branch block (HP:0011710) | 1.99717770 |
| 87 | Abnormality of glycolysis (HP:0004366) | 1.99388110 |
| 88 | Scapular winging (HP:0003691) | 1.99355123 |
| 89 | Late onset (HP:0003584) | 1.97305929 |
| 90 | Hyponatremia (HP:0002902) | 1.97141104 |
| 91 | Easy fatigability (HP:0003388) | 1.95204470 |
| 92 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.91316866 |
| 93 | Generalized amyotrophy (HP:0003700) | 1.90501470 |
| 94 | Abnormality of the calcaneus (HP:0008364) | 1.90492685 |
| 95 | Generalized hyperpigmentation (HP:0007440) | 1.88869437 |
| 96 | Dicarboxylic aciduria (HP:0003215) | 1.86100174 |
| 97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86100174 |
| 98 | Sudden death (HP:0001699) | 1.85517062 |
| 99 | Increased serum lactate (HP:0002151) | 1.85481583 |
| 100 | Ragged-red muscle fibers (HP:0003200) | 1.83594981 |
| 101 | Weak cry (HP:0001612) | 1.82484033 |
| 102 | Axonal loss (HP:0003447) | 1.82093699 |
| 103 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.82077539 |
| 104 | Subaortic stenosis (HP:0001682) | 1.82077539 |
| 105 | Progressive external ophthalmoplegia (HP:0000590) | 1.81981947 |
| 106 | Metabolic acidosis (HP:0001942) | 1.81412356 |
| 107 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.81297615 |
| 108 | Insomnia (HP:0100785) | 1.80831698 |
| 109 | Lipoatrophy (HP:0100578) | 1.79922957 |
| 110 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.78427560 |
| 111 | Increased intramyocellular lipid droplets (HP:0012240) | 1.77930334 |
| 112 | Vertebral compression fractures (HP:0002953) | 1.77700992 |
| 113 | Hypertensive crisis (HP:0100735) | 1.77277044 |
| 114 | Pathologic fracture (HP:0002756) | 1.76551388 |
| 115 | Stridor (HP:0010307) | 1.75494084 |
| 116 | Areflexia of lower limbs (HP:0002522) | 1.74231640 |
| 117 | Asymmetric septal hypertrophy (HP:0001670) | 1.72653158 |
| 118 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.70505179 |
| 119 | Hyperammonemia (HP:0001987) | 1.70326402 |
| 120 | Congenital hip dislocation (HP:0001374) | 1.69937172 |
| 121 | Calf muscle hypertrophy (HP:0008981) | 1.69840785 |
| 122 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.69738306 |
| 123 | Mitochondrial inheritance (HP:0001427) | 1.69588863 |
| 124 | Lactic acidosis (HP:0003128) | 1.69437188 |
| 125 | Difficulty running (HP:0009046) | 1.69271968 |
| 126 | Absent phalangeal crease (HP:0006109) | 1.69243851 |
| 127 | Round ear (HP:0100830) | 1.68951583 |
| 128 | Basal cell carcinoma (HP:0002671) | 1.68936558 |
| 129 | Cerebral hypomyelination (HP:0006808) | 1.68922875 |
| 130 | Fetal akinesia sequence (HP:0001989) | 1.68552588 |
| 131 | Abnormal atrioventricular conduction (HP:0005150) | 1.67458011 |
| 132 | Dilated cardiomyopathy (HP:0001644) | 1.67434803 |
| 133 | Muscle fiber atrophy (HP:0100295) | 1.65983899 |
| 134 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.65969253 |
| 135 | Respiratory failure (HP:0002878) | 1.65277342 |
| 136 | Increased CSF lactate (HP:0002490) | 1.65024781 |
| 137 | Papilloma (HP:0012740) | 1.64051505 |
| 138 | Verrucae (HP:0200043) | 1.64051505 |
| 139 | Increased serum pyruvate (HP:0003542) | 1.63505937 |
| 140 | Acute necrotizing encephalopathy (HP:0006965) | 1.63054594 |
| 141 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.62468442 |
| 142 | Distal lower limb muscle weakness (HP:0009053) | 1.61246612 |
| 143 | Gowers sign (HP:0003391) | 1.60418469 |
| 144 | Muscular dystrophy (HP:0003560) | 1.52222394 |
| 145 | Waddling gait (HP:0002515) | 1.50872132 |
| 146 | Neoplasm of head and neck (HP:0012288) | 1.49649799 |
| 147 | Esophageal neoplasm (HP:0100751) | 1.49649799 |
| 148 | Abnormal finger flexion creases (HP:0006143) | 1.49434095 |
| 149 | Shoulder girdle muscle weakness (HP:0003547) | 1.47989977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 3.82491928 |
| 2 | PHKG1 | 3.33786934 |
| 3 | PHKG2 | 3.33786934 |
| 4 | NME2 | 3.16808877 |
| 5 | PRPF4B | 3.09162078 |
| 6 | BCKDK | 2.63085766 |
| 7 | TLK1 | 2.49771282 |
| 8 | TRIB3 | 2.41463850 |
| 9 | NEK1 | 2.38589769 |
| 10 | MAP3K11 | 2.24206431 |
| 11 | PKN2 | 2.17470123 |
| 12 | SMG1 | 2.10461692 |
| 13 | TESK2 | 2.08738828 |
| 14 | BUB1 | 2.07711409 |
| 15 | TTN | 2.04960536 |
| 16 | MAP4K1 | 1.98906763 |
| 17 | ICK | 1.97422117 |
| 18 | STK10 | 1.96258326 |
| 19 | FLT3 | 1.94766637 |
| 20 | CDC7 | 1.90171734 |
| 21 | EEF2K | 1.87999027 |
| 22 | TESK1 | 1.86857894 |
| 23 | KDR | 1.84921515 |
| 24 | MAPKAPK3 | 1.82963657 |
| 25 | VRK2 | 1.82423424 |
| 26 | CDK12 | 1.80325992 |
| 27 | PDK3 | 1.70414584 |
| 28 | PDK4 | 1.70414584 |
| 29 | STK4 | 1.69602104 |
| 30 | ERN1 | 1.67767182 |
| 31 | CCNB1 | 1.57693636 |
| 32 | MAPK12 | 1.54989727 |
| 33 | MAP3K10 | 1.50237846 |
| 34 | MAP2K3 | 1.45087872 |
| 35 | PIM2 | 1.42744938 |
| 36 | TSSK6 | 1.40967825 |
| 37 | BRSK1 | 1.40756779 |
| 38 | OBSCN | 1.36741539 |
| 39 | MAP3K8 | 1.36076773 |
| 40 | LRRK2 | 1.35686418 |
| 41 | ARAF | 1.35070677 |
| 42 | RPS6KB2 | 1.26342059 |
| 43 | NEK2 | 1.26265453 |
| 44 | ZAK | 1.21585009 |
| 45 | SCYL2 | 1.18118557 |
| 46 | PIK3CG | 1.17296231 |
| 47 | MAPK11 | 1.16963760 |
| 48 | GRK6 | 1.06800066 |
| 49 | TYK2 | 1.05307037 |
| 50 | PIK3CA | 1.00808974 |
| 51 | ZAP70 | 1.00072264 |
| 52 | TBK1 | 0.96469480 |
| 53 | PAK4 | 0.96118064 |
| 54 | WEE1 | 0.96014344 |
| 55 | MOS | 0.89729945 |
| 56 | VRK1 | 0.87162394 |
| 57 | LMTK2 | 0.86574070 |
| 58 | DYRK3 | 0.85738788 |
| 59 | PASK | 0.85248073 |
| 60 | PIM1 | 0.84640403 |
| 61 | MAP3K1 | 0.84106292 |
| 62 | TRPM7 | 0.83864367 |
| 63 | EPHA2 | 0.82985288 |
| 64 | AURKA | 0.82755010 |
| 65 | TAOK2 | 0.81903871 |
| 66 | AURKB | 0.81847539 |
| 67 | MAP2K2 | 0.81559897 |
| 68 | MST1R | 0.80662531 |
| 69 | DAPK3 | 0.79264138 |
| 70 | LIMK1 | 0.75890026 |
| 71 | CDK4 | 0.73854370 |
| 72 | MAP3K13 | 0.71728725 |
| 73 | RIPK1 | 0.69862841 |
| 74 | NME1 | 0.69434507 |
| 75 | MTOR | 0.69370262 |
| 76 | MAP2K6 | 0.69145988 |
| 77 | RPS6KA5 | 0.67928913 |
| 78 | ILK | 0.67492298 |
| 79 | STK16 | 0.67336016 |
| 80 | KSR2 | 0.67126608 |
| 81 | PLK1 | 0.67012760 |
| 82 | SYK | 0.66630539 |
| 83 | DYRK1B | 0.65848444 |
| 84 | PDK2 | 0.65577722 |
| 85 | PDPK1 | 0.63823145 |
| 86 | IKBKB | 0.62619679 |
| 87 | MUSK | 0.62108639 |
| 88 | MAPKAPK2 | 0.59390515 |
| 89 | RPS6KL1 | 0.58745408 |
| 90 | STK24 | 0.57804939 |
| 91 | DMPK | 0.56721960 |
| 92 | JAK3 | 0.56138043 |
| 93 | CDK8 | 0.55742243 |
| 94 | RPS6KA4 | 0.55616445 |
| 95 | NEK9 | 0.54052458 |
| 96 | MST4 | 0.53667761 |
| 97 | BRSK2 | 0.53608917 |
| 98 | MAP3K7 | 0.53253731 |
| 99 | SIK1 | 0.52950146 |
| 100 | CDK7 | 0.52561305 |
| 101 | CAMK2G | 0.51085074 |
| 102 | TAOK1 | 0.50336912 |
| 103 | MYLK | 0.50204648 |
| 104 | HIPK2 | 0.49468063 |
| 105 | MAP3K3 | 0.47842446 |
| 106 | PRKG2 | 0.47475570 |
| 107 | MET | 0.47084233 |
| 108 | DAPK1 | 0.46652318 |
| 109 | IKBKE | 0.46514337 |
| 110 | PAK1 | 0.45479402 |
| 111 | TIE1 | 0.45360187 |
| 112 | BMX | 0.44383017 |
| 113 | ABL2 | 0.44318628 |
| 114 | EPHB1 | 0.43646390 |
| 115 | CDC42BPA | 0.42349475 |
| 116 | MAPK4 | 0.41463042 |
| 117 | ATR | 0.40112565 |
| 118 | BRAF | 0.39233658 |
| 119 | CHEK1 | 0.39037359 |
| 120 | AKT2 | 0.38883386 |
| 121 | RPS6KA6 | 0.38323324 |
| 122 | SIK3 | 0.37927885 |
| 123 | BTK | 0.37434966 |
| 124 | IRAK3 | 0.36994079 |
| 125 | PINK1 | 0.36785522 |
| 126 | IRAK2 | 0.36651474 |
| 127 | MAP2K1 | 0.36627651 |
| 128 | JAK2 | 0.36383457 |
| 129 | PRKD2 | 0.36173926 |
| 130 | CSNK2A1 | 0.36090341 |
| 131 | CAMK4 | 0.36059826 |
| 132 | CDK6 | 0.35961677 |
| 133 | TTK | 0.35037574 |
| 134 | RPS6KC1 | 0.34423376 |
| 135 | MARK2 | 0.32371059 |
| 136 | PDK1 | 0.32155109 |
| 137 | MAPKAPK5 | 0.31446768 |
| 138 | PRKD3 | 0.31065434 |
| 139 | MARK3 | 0.30766378 |
| 140 | RAF1 | 0.30746052 |
| 141 | RPS6KA2 | 0.29097386 |
| 142 | CHEK2 | 0.28324045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 4.23785226 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.55255565 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.18701357 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.91111717 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 2.86008572 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.58625845 |
| 7 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.41720386 |
| 8 | Carbon metabolism_Homo sapiens_hsa01200 | 2.09772485 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.09280553 |
| 10 | Ribosome_Homo sapiens_hsa03010 | 2.03326707 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.00773594 |
| 12 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.93319728 |
| 13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.85128829 |
| 14 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.82053408 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.81594353 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.74400479 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72030290 |
| 18 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.70510798 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.70491503 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.68540414 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65996458 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.64954063 |
| 23 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.55538227 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.42690712 |
| 25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.42301317 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.41989468 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41820653 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.40533983 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36768286 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36310820 |
| 31 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.35899859 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.34396590 |
| 33 | Cell cycle_Homo sapiens_hsa04110 | 1.32885002 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32566706 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32327268 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.30852755 |
| 37 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.30328246 |
| 38 | Spliceosome_Homo sapiens_hsa03040 | 1.25932304 |
| 39 | Homologous recombination_Homo sapiens_hsa03440 | 1.22419629 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.21402300 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.17875464 |
| 42 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.17800053 |
| 43 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.17676808 |
| 44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09689368 |
| 45 | RNA transport_Homo sapiens_hsa03013 | 1.09647000 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02495607 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00080373 |
| 48 | * Nucleotide excision repair_Homo sapiens_hsa03420 | 0.98285632 |
| 49 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97492829 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.97276749 |
| 51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.97171399 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96117484 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93975573 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 0.92526465 |
| 55 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86207070 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85377037 |
| 57 | RNA polymerase_Homo sapiens_hsa03020 | 0.83639895 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83154928 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82057147 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.81984744 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.79937978 |
| 62 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79548637 |
| 63 | Alcoholism_Homo sapiens_hsa05034 | 0.79441101 |
| 64 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78636963 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76718184 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76698337 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.76086727 |
| 68 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.75989818 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75468390 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75036215 |
| 71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.71415820 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71377526 |
| 73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71281743 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70335603 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.69950896 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69683551 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69659189 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68765980 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68253664 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67576914 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.65238245 |
| 82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64422101 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.63978256 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61281841 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60372366 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60161160 |
| 87 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.56760379 |
| 88 | Protein export_Homo sapiens_hsa03060 | 0.56365045 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56053940 |
| 90 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55465329 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.54568997 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.54193353 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53745800 |
| 94 | Measles_Homo sapiens_hsa05162 | 0.53317028 |
| 95 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53016986 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52116198 |
| 97 | RNA degradation_Homo sapiens_hsa03018 | 0.51805803 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.51734843 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51329466 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51081298 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48868572 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48568296 |
| 103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47233277 |
| 104 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46691530 |
| 105 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46574001 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45585870 |
| 107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45345145 |
| 108 | Purine metabolism_Homo sapiens_hsa00230 | 0.45096911 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43414906 |
| 110 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.41946996 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41123156 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38935466 |
| 113 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38739823 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.38115505 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37855313 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.37637538 |
| 117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37121626 |
| 118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36170806 |
| 119 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35615396 |
| 120 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.35522163 |
| 121 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.35395435 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34090262 |
| 123 | Hepatitis B_Homo sapiens_hsa05161 | 0.33867924 |
| 124 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32992533 |
| 125 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.32732614 |
| 126 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.32714012 |
| 127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32571732 |
| 128 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.31032969 |
| 129 | Shigellosis_Homo sapiens_hsa05131 | 0.30995001 |
| 130 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30309869 |
| 131 | Viral myocarditis_Homo sapiens_hsa05416 | 0.28914296 |
| 132 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28902050 |
| 133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27993124 |
| 134 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27721682 |
| 135 | Long-term potentiation_Homo sapiens_hsa04720 | 0.27196431 |

